Real-time bioluminescence imaging of mixed mycobacterial infections

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Chang, Mihee ^a   Anttonen, Katri P ^a   Cirillo, Suat L G ^a   Francis, Kevin P ^b   Cirillo, Jeffrey D ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b PERKINELMER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL VACCINE; ISONIAZID PLUS RIFAMPICIN; LUCIFERASE; FIREFLY LUCIFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; BEETLE; BIOLUMINESCENCE; CONTROLLED STUDY; DRUG SCREENING; FEMALE; IMAGING SYSTEM; MIXED INFECTION; MOLECULAR IMAGING; MOUSE; MYCOBACTERIOSIS; NONHUMAN; PATHOGENESIS; PHOTINUS PYRALIS; PYROPHORUS PLAGIOPHTHALAMUS; REPORTER GENE; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CLASSIFICATION; COINFECTION; DIAGNOSTIC IMAGING; GENETICS; LUMINESCENCE; MACROPHAGE; MICROBIOLOGY; MOLECULAR GENETICS; MYCOBACTERIUM TUBERCULOSIS; PHOTORHABDUS; PROCEDURES; TUBERCULOSIS, PULMONARY;

ANIMALS; CELL LINE; COINFECTION; DIAGNOSTIC IMAGING; FEMALE; LUCIFERASES, FIREFLY; LUMINESCENT MEASUREMENTS; MACROPHAGES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; PHOTORHABDUS; TUBERCULOSIS, PULMONARY;

EID: 84907528196     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108341     Document Type: Article

References (64)

1. WHO (2013) Global tuberculosis report 2013. Geneva, Switzerland: World Health Organization. 1-289 p
2. Evans TG, Brennan MJ, Barker L, Thole J (2013) Preventive vaccines for tuberculosis. Vaccine 31 Suppl 2: B223-226
3. Tameris MD, Hatherill M, Landry BS, Scriba TJ, Snowden MA, et al. (2013) Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: A randomised, placebo-controlled phase 2b trial. Lancet 381: 1021-1028
4. Cole ST, Brosh R, Parkhill J, Garnier T, Churcher C, et al. (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393: 537-544
5. Cole ST (2002) Comparative and functional genomics of the Mycobacterium tuberculosis complex. Microbiology 148: 2919-2928
6. Kong Y, Subbian S, Cirillo SL, Cirillo JD (2009) Application of optical imaging to study of extrapulmonary spread by tuberculosis. Tuberculosis (Edinb) 89 Suppl 1: S15-17
7. Kong Y, Akin AR, Francis KP, Zhang N, Troy TL, et al. (2011) Whole-body imaging of infection using fluorescence. Curr Protoc Microbiol Chapter 2: Unit2C 3
8. Mufti N, Kong Y, Cirillo JD, Maitland KC (2011) Fiber optic microendoscopy for preclinical study of bacterial infection dynamics. Biomed Opt Express 2: 1121-1134
9. Kong Y, Yao H, Ren H, Subbian S, Cirillo SL, et al. (2010) Imaging tuberculosis with endogenous {beta}-lactamase reporter enzyme fluorescence in live mice. Proc Natl Acad Sci U S A
10. Kong Y, Cirillo JD (2010) Reporter enzyme fluorescence (REF) imaging and quantification of tuberculosis in live animals. Virulence 1: 558-562
11. Xie H, Mire J, Kong Y, Chang M, Hassounah HA, et al. (2012) Rapid point-ofcare detection of the tuberculosis pathogen using a BlaC-specific fluorogenic probe. Nat Chem 4: 802-809
12. Bartzatt R, Sule P, Cirillo SLG, Cirillo JD (2014) Novel tuberculostatic agents suitable for treatment of Mycobacterium tuberculosis infections of the central nervous system. Brit J Pharm Res 4: 1535-1551
13. Kapoor R, Eimerman PR, Hardy JW, Cirillo JD, Contag CH, et al. (2011) Efficacy of Antimicrobial Peptoids against Mycobacterium tuberculosis. Antimicrob Agents Chemother 55: 3058-3062
14. Singh V, Biswas RK, Singh BN (2014) Double recombinant Mycobacterium bovis BCG strain for screening of primary and rationale-based antimycobacterial compounds. Antimicrob Agents Chemother 58: 1389-1396
15. Zhang T, Li SY, Nuermberger EL (2012) Autoluminescent Mycobacterium tuberculosis for rapid, real-time, non-invasive assessment of drug and vaccine efficacy. PLoS One 7: E29774
16. Andreu N, Fletcher T, Krishnan N, Wiles S, Robertson BD (2012) Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence. J Antimicrob Chemother 67: 404-414
17. Andreu N, Zelmer A, Fletcher T, Elkington PT, Ward TH, et al. (2010) Optimisation of bioluminescent reporters for use with mycobacteria. PLoS One 5: E10777
18. Andreu N, Zelmer A, Sampson SL, Ikeh M, Bancroft GJ, et al. (2013) Rapid in vivo assessment of drug efficacy against Mycobacterium tuberculosis using an improved firefly luciferase. J Antimicrob Chemother 68: 2118-2127
19. Zhang T, Li SY, Converse PJ, Almeida DV, Grosset JH, et al. (2011) Using bioluminescence to monitor treatment response in real time in mice with Mycobacterium ulcerans infection. Antimicrob Agents Chemother 55: 56-61
20. Dothager RS, Flentie K, Moss B, Pan MH, Kesarwala A, et al. (2009) Advances in bioluminescence imaging of live animal models. Curr Opin Biotechnol 20: 45-53
21. Campbell-Valois FX, Sansonetti PJ (2014) Tracking bacterial pathogens with genetically-encoded reporters. FEBS Lett 588: 2428-2436
22. Andreu N, Zelmer A, Wiles S (2011) Noninvasive biophotonic imaging for studies of infectious disease. FEMS Microbiol Rev 35: 360-394
23. Hutchens M, Luker GD (2007) Applications of bioluminescence imaging to the study of infectious diseases. Cell Microbiol 9: 2315-2322
24. Contag CH, Bachmann MH (2002) Advances in in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng 4: 235-260
25. Kong Y, Shi Y, Chang M, Akin AR, Francis KP, et al. (2011) Whole-body imaging of infection using bioluminescence. Curr Protoc Microbiol Chapter 2: Unit2C 4
26. Chang MH, Cirillo SL, Cirillo JD (2011) Using luciferase to image bacterial infections in mice. J Vis Exp
27. Sharma S, Gelman E, Narayan C, Bhattacharjee D, Achar V, et al. (2014) A simple and rapid method to determine antimycobacterial potency of compounds using autoluminescent Mycobacterium tuberculosis. Antimicrob Agents Chemother
28. Hyde JA, Weening EH, Chang M, Trzeciakowski JP, Hook M, et al. (2011) Bioluminescent imaging of Borrelia burgdorferi in vivo demonstrates that the fibronectin-binding protein BBK32 is required for optimal infectivity. Mol Microbiol 82: 99-113
29. Lee J, Attila C, Cirillo SLG, Cirillo JD, Wood TK (2009) Indole and 7- hydroxyindole diminish Pseudomonas aeruginosa virulence. Microbial Biotechnol 2: 75-90
30. Heuts F, Carow B, Wigzell H, Rottenberg ME (2009) Use of non-invasive bioluminescent imaging to assess mycobacterial dissemination in mice, treatment with bactericidal drugs and protective immunity. Microbes Infect 11: 1114-1121
31. Andrew PW, Roberts IS (1993) Construction of a bioluminescent mycobacterium and its use for assay of antimycobacterial agents. J Clin Microbiol 31: 2251-2254
32. Waidmann MS, Bleichrodt FS, Laslo T, Riedel CU (2011) Bacterial luciferase reporters: the Swiss army knife of molecular biology. Bioeng Bugs 2: 8-16
33. Meighen EA (1994) Genetics of bacterial bioluminescences. Annu Rev Genet 28: 117-139
34. Frackman S, Anhalt M, Nealson KH (1990) Cloning, organization, and expression of the bioluminescence genes of Xenorhabdus luminescens. J Bacteriol 172: 5767-5773
35. Contag CH, Contag PR, Mullins JI, Spilman SD, Stevenson DK, et al. (1995) Photonic detection of bacterial pathogens in living hosts. Mol Microbiol 18: 593-603
36. Cooksey RC, Crawford JT, Jacobs WR Jr, Shinnick TM (1993) A rapid method for screening antimicrobial agents for activities against a strain of Mycobacterium tuberculosis expressing firefly luciferase. Antimicrob Agents Chemother 37: 1348-1352
37. Arain TM, Resconi AE, Hickey MJ, Stover CK (1996) Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery. Antimicrob Agents Chemother 40: 1536-1541
38. Hickey MJ, Arain TM, Shawar RM, Humble DJ, Langhorne MH, et al. (1996) Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice. Antimicrob Agents Chemother 40: 400-407
39. Rice BW, Cable MD, Nelson MB (2001) In vivo imaging of light-emitting probes. J Biomed Opt 6: 432-440
40. Zhao H, Doyle TC, Coquoz O, Kalish F, Rice BW, et al. (2005) Emission spectra of bioluminescent reporters and interaction with mammalian tissue determine the sensitivity of detection in vivo. J Biomed Opt 10: 41210
41. Difco (1984) Difco Manual: Dehydrated Culture Media and Reagents for Microbiology. Detroit, MI: Difco Laboratories
42. Mehta PK, Pandey AK, Subbian S, El-Etr SH, Cirillo SL, et al. (2006) Identification of Mycobacterium marinum macrophage infection mutants. Microb Pathog 40: 139-151
43. Miltner E, Daroogheh K, Mehta PK, Cirillo SLG, Cirillo JD, et al. (2005) Identification of Mycobacterium avium genes that affect invasion of the intestinal epithelium. Infect Immun 73: 4214-4221
44. Cirillo SLG, Lum J, Cirillo JD (2000) Identification of novel loci involved in entry by Legionella pneumophila. Microbiology 146: 1345-1359
45. Barletta RG, Kim DD, Snapper SB, Bloom BR, Jacobs WR Jr (1992) Identification of expression signals of the mycobacteriophages Bxb1, L1, and TM4 using Escherichia-Mycobacterium shuttle plasmids pYUB75 and pYUB76 designed to create translational fusions to the lacZ gene. J Gen Microbiol 138: 23-30
46. Park B, Subbian S, El-Etr SH, Cirillo SL, Cirillo JD (2008) Use of gene dosage effects for a whole-genome screen to identify Mycobacterium marinum macrophage infection loci. Infect Immun 76: 3100-3115
47. Stolt P, Stoker NG (1996) Functional definition of regions necessary for replication and incompatibility in the Mycobacterium fortuitum plasmid pAL5000. Microbiol 142: 2795-2802
48. Subbian S, Mehta PK, Cirillo SL, Bermudez LE, Cirillo JD (2007) A Mycobacterium marinum mel2 mutant is defective for growth in macrophages that produce reactive oxygen and reactive nitrogen species. Infect Immun 75: 127-134
49. Luker KE, Luker GD (2010) Bioluminescence imaging of reporter mice for studies of infection and inflammation. Antiviral Res 86: 93-100
50. Branchini BR, Ablamsky DM, Davis AL, Southworth TL, Butler B, et al. (2010) Red-emitting luciferases for bioluminescence reporter and imaging applications. Anal Biochem 396: 290-297
51. Hardy J, Francis KP, DeBoer M, Chu P, Gibbs K, et al. (2004) Extracellular replication of Listeria monocytogenes in the murine gall bladder. Science 303: 851-853
52. Francis KP, Yu J, Bellinger-Kawahara C, Joh D, Hawkinson MJ, et al. (2001) Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposon. Infect Immun 69: 3350-3358
53. Janagama HK, Hassounah HA, Cirillo SL, Cirillo JD (2011) Random inducible controlled expression (RICE) for identification of mycobacterial virulence genes. Tuberculosis (Edinb) 91 Suppl 1: S66-68
54. Danelishvili L, Wu M, Stang B, Harriff M, Cirillo SL, et al. (2007) Identification of Mycobacterium avium pathogenicity island important for macrophage and amoeba infection. Proc Natl Acad Sci U S A 104: 11038-11043
55. Chackerian AA, Alt JM, Perera TV, Dascher CC, Behar SM (2002) Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity. Infect Immun 70: 4501-4509
56. Zelmer A, Carroll P, Andreu N, Hagens K, Mahlo J, et al. (2012) A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging. J Antimicrob Chemother 67: 1948-1960
57. Wayne LG, Gross WM (1968) Base composition of deoxyribonucleic acid isolated from mycobacteria. J Bacteriol 96: 1915-1919
58. Wayne LG, Kubica GP (1986) Mycobacteria. In: Sneath PHA, Mair NS, Sharpe ME, Holt JG, editors. Bergey's Manual of Systematic Bacteriology. Baltimore: Williams & Wilkins. 1436-1457
59. Imaeda T (1985) Deoxyribonucleic acid relatedness among selected strains of Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium bovis BCG, Mycobacterium microti, and Mycobacterium africanum. Int J Syst Bacteriol 35: 147-150
60. Foucault ML, Thomas L, Goussard S, Branchini BR, Grillot-Courvalin C (2010) In vivo bioluminescence imaging for the study of intestinal colonization by Escherichia coli in mice. Appl Environ Microbiol 76: 264-274
61. Mezzanotte L, Que I, Kaijzel E, Branchini B, Roda A, et al. (2011) Sensitive dual color in vivo bioluminescence imaging using a new red codon optimized firefly luciferase and a green click beetle luciferase. PLoS One 6: E19277
62. Ranes MG, Rauzier J, Lagranderie M, Gheorghiu M, Gicquel B (1990) Functional analysis of pAL5000, a plasmid from Mycobacterium fortuitum: construction of a ''mini'' Mycobacterium-Escherichia coli shuttle vector. J Bacteriol 172: 2793-2797
63. Stover CK, de la Cruz VF, Fuerst TR, Burlein JE, Benson LA, et al. (1991) New use of BCG for recombinant vaccines. Nature 351: 456-460
64. Lee MH, Pascopella L, Jacobs WR Jr, Hatfull GF (1991) Site-specific integration of mycobacteriophage L5: integration-proficient vectors for Mycobacterium smegmatis, BCG, and M. tuberculosis. Proc Natl Acad Sci USA 88: 3111-3115